ERBB2 and breast cancer: Furthermore, in the orthotopic MDA‐MB‐468‐HER2 breast cancer model, FLAG‐CAR 4 T cells alone or the H‐FLAG alone had minimal impact on tumor growth, but their combination led to significant tumor regression (Figure 7d), demonstrating the efficacy of this modular targeting strategy in vivo.